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Epothilones are thiazole-containing natural products with anticancer
activity that are biosynthesized by polyketide synthase (PKS)-
nonribosomal peptide synthetase (NRPS) enzymes EpoA–F. A cycliza-
tion domain of EpoB (Cy) assembles the thiazole functionality from
an acetyl group and L-cysteine via condensation, cyclization, and de-
hydration. The PKS carrier protein of EpoA contributes the acetyl
moiety, guided by a docking domain, whereas an NRPS EpoB carrier
protein contributes L-cysteine. To visualize the structure of a cycliza-
tion domain with an accompanying docking domain, we solved a
2.03-Å resolution structure of this bidomain EpoB unit, comprising
residues M1-Q497 (62 kDa) of the 160-kDa EpoB protein.We find that
the N-terminal docking domain is connected to the V-shaped Cy do-
main by a 20-residue linker but otherwise makes no contacts to Cy.
Molecular dynamic simulations and additional crystal structures re-
veal a high degree of flexibility for this docking domain, emphasizing
the modular nature of the components of PKS-NRPS hybrid systems.
These structures further reveal two 20-Å-long channels that run from
distant sites on the Cy domain to the active site at the core of the
enzyme, allowing two carrier proteins to dock with Cy and deliver
their substrates simultaneously. Through mutagenesis and activity
assays, catalytic residues N335 and D449 have been identified. Sur-
prisingly, these residues do not map to the location of the conserved
HHxxxDG motif in the structurally homologous NRPS condensation
(C) domain. Thus, although both C and Cy domains have the same
basic fold, their active sites appear distinct.
crystal structure | molecular dynamics | epothilone | natural product
Epothilones are hybrid polyketide/nonribosomal peptide naturalproducts indicated for treatment of metastatic or locally ad-
vanced breast cancers that are taxane resistant (1, 2). They contain
a large macrocycle with a thiazole-containing side chain, which is
important for stabilizing microtubules and impairing cell division
(Fig. 1A) (3, 4). Azole heterocycles, such as thiazoles, are com-
monly found in many natural products and in different oxidation
states (i.e., azolines and azolidines). They are more resistant to
hydrolysis than a peptide bond, and their incorporation can in-
crease a compound’s affinity for a target biomolecule (5). Despite
their importance, there is still much to learn about the structure
and mechanism of the enzymes involved in their biosynthesis (6, 7).
Here we explore the structural basis of activity of the catalytic do-
main that generates the 2-methylthiazoline precursor of epothilone
natural products.
The epothilone biosynthetic gene cluster from Sorangium cellu-
losum is encoded by epoA-K (Fig. 1A). EpoA, a polyketide synthase
(PKS), and EpoB, a nonribosomal peptide synthetase (NRPS), are
responsible for making the 2-methylthiazole functionality (8–11).
2-methylthiazole derives from the condensation of an acetyl group
with L-cysteine (Fig. 1B). Before condensation, the acetyl moiety and
L-cysteine are covalently attached to the carrier T domains of EpoA
(acetyl-S-EpoA-T) and EpoB (cysteinyl-S-EpoB-T), respectively, via
phosphopantetheine (Ppant) linkers (Fig. 1A and Fig. S1). Instead of
a traditional condensation or C domain, EpoB has a cyclization (Cy)
domain that performs both the amide bond forming condensation
reaction and the cyclization/dehydration to form the five-membered
ring structure of 2-methylthiazoline (10). Two mechanisms have
been proposed that differ in whether the amide bond forms first or
second to the cyclization reaction (12, 13) (Fig. 1B). Subsequent
oxidation by the flavin-dependent oxidase domain (EpoB-Ox)
results in 2-methylthiazole (8, 10, 11). PKS-NRPS docking do-
mains (14), referred to as EpoAdd and EpoBdd for the upstream
donor and the downstream acceptor proteins, respectively, serve
to localize the T domains to the appropriate intermodule junction,
facilitating what has often been referred to as an assembly line
biosynthetic process.
There is much that is unknown about Cy domains; the molecular
basis for the differentiation of C and Cy domain activity is not
established, and the key catalytic residues have not been identified.
Keating et al. predicted that the C and Cy domains would adopt
similar structures (15), and early sequence alignments identified
a DxxxxDxxS Cy domain sequence that replaces the C domain
HHxxxDG catalytic motif (Fig. S2). Although conservation of the
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DxxxxDxxS sequence within known Cy domains suggests its im-
portance, mutational analyses have been inconclusive as to which
residues are critical for catalysis (13, 16, 17).
To provide insight into the cyclization activity of EpoB, we de-
termined the X-ray structures of an EpoB construct that contains
residues M1-Q497 (∼62 kDa) of the full-length EpoB enzyme from
S. cellulosum. This 62-kDa unit, which we will call EpoBcy, was
previously shown (17) to be an active Cy domain, capable of inter-
acting in trans with constructs encoding the A, Ox, and T-domains of
EpoB and the T domain of EpoA to synthesize 2-methylthiazole.
This construct also contains the cognate N-terminal docking do-
main, providing the first glimpse of this PKS to NRPS docking
domain within a larger protein. These structural results, along with
accompanying mutagenesis data, provide insights into the molecular
basis of cyclization activity and have important implications re-
garding PKS-NRPS interprotein interactions.
Results
Structure of an NRPS Cy and Docking Bidomain.We determined two
structures of EpoBcy in two different space groups. A 2.6-Å res-
olution structure of EpoBcy was solved, with two molecules in the
asymmetric unit, in space group R32, by multiple isomorphous
replacement techniques using data from five different heavy atom
derivatives (Tables S1 and S2). A 2.03-Å resolution structure was
solved in space group P21, using R32-EpoBcy as a molecular re-
placement search model, with one molecule per asymmetric unit
(Table S2). The overall protein fold of the Cy domain (D76–Q497)
of EpoB is V-shaped, with the N- and C-terminal segments each
comprising approximately one half of the V (Fig. 2A). The N- and
C-terminal segments (D76–K247 and S248–Q497, respectively)
contain αβα sandwich folds, resulting in a structure that loosely
resembles a pseudodimer. The N-terminal segment of the Cy do-
main consists of a five-stranded mixed β-sheet in which the last
β-strand is donated from the adjacent C-terminal half of the pro-
tein, and the C-terminal segment contains a mixed six-stranded
β-sheet positioned almost perpendicular to the N-terminal β-sheet.
This protein fold is similar to that of both NRPS condensation
domains (15, 18–21) and epimerization or E domains (22, 23). For
example, EpoBcy aligns with VibH from vibriobactin synthetase
(15) with an overall RMSD of 3.9 Å for 392 Cα atoms (Fig. 2B).
The N-terminal 55 residues of the EpoB protein make up the
docking domain (EpoBdd), which recognizes the upstream
EpoAdd to position the acetyl-S-EpoA-T domain for catalysis
(24). EpoBdd adopts an αββαα fold, consisting of an initial α-helix,
β-turn, and two final α-helices (Fig. 2A), and is connected to the
Cy domain by a 20-residue linker (L56–T75). There is one other
Fig. 1. Scheme for epothilone biosynthesis, focusing on thiazol(in)e formation by the NRPS cyclization domain. (A) Epothilones (Right) are large macrocycles with
a thiazole-containing side chain (red), which are produced by a hybrid PKS-NRPS, EpoA-K. EpoA and EpoB are responsible for producing the thiazole side chain
and have the following domains (8–11): KSy, ketosynthase-like domain; AT, acyltransferase domain; ER, enoyl reductase; and T, an acyl carrier protein. The NRPS
EpoB domains include the following: A, adenylation domain; Cy, cyclization; Ox, a flavin-dependent oxidase domain; and T, a carrier protein domain (29). The
Ppant group of each T domain is represented as a squiggly line and residue numberings for the EpoA-T, and EpoBcy constructs are indicated. (B) Proposed
mechanisms for condensation and cyclodehydration. The EpoA-T domain and EpoB-T domains are represented as red and blue spheres, respectively.
Fig. 2. Overall structure of EpoBcy. (A) (Left) Ribbon structure of monomeric
EpoBcy, with the N-terminal docking domain in cyan, and the N- and C-terminal
halves of the Cy domain in purple and yellow, respectively. (Right) Topology
diagram of EpoBcy generated using TOPDRAW (31). (B) Structural superimpo-
sition of the NRPS Cy and C domains. The EpoB Cy domain is colored as in A; the
C domain from VibH is colored in gray (PDB ID code 1L5A) (15). Helices are
represented as cylinders, and the EpoB docking domain is omitted for clarity.
(Inset) Close-up view of the C domain H125-H126-xxx-D130-G131 motif and the
respective Cy domain D201-xxxx-D206-xx-S209 sequence, depicted as sticks.
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docking domain structure with this fold, TubCdd from the
Angiococcus disciformitus tubulysin system (14). This docking do-
main functions at an NRPS-NRPS junction and shares with
EpoBdd 33% sequence identity and an RMSD of 3.6 Å for 52 Cα
atoms (Fig. S3) (14). The β-hairpin and the third α-helix (α3′) of
the αββαα fold show the largest deviation between these two
docking domain structures (Fig. S3). In EpoBdd, the β-hairpin is
tipped inward slightly toward α2′, whereas α3′ is swung slightly
away from the structural core (Fig. S3D). This difference in the
β-hairpin is interesting given that this region is predicted to be a
binding site of the cognate recognition sequence (14, 25). How-
ever, it is not currently clear if theses variations are mechanistically
significant or an artifact of a difference in oligomeric state. In so-
lution and without its cognate protein, TubCdd is a dimer, whereas
EpoBdd is monomeric in our structure. Notably, the β-hairpin and
the third α-helix (α3′) are both involved in the TubCdd dimer
interface. Unfortunately, no structure of TubCdd with a partner
protein is available that could clarify the relevance of the dimeric
unit and provide additional information about protein interac-
tion specificity.
Structures and MD Simulations Reveal Conformational Flexibility of
Docking Domain. Three different conformations of the docking
domain are observed in our structures, consistent with the presence
of a flexible rather than rigid linker between the docking and Cy
domains, and the existence of very little buried surface at the do-
main–domain interface in any of the structures (Fig. 3A and Fig. S4).
The R32 crystal form reveals two conformations of the docking
domain, with each molecule in the asymmetric unit adopting a dif-
ferent conformation. A third orientation is visible in the P21-EpoBcy
structure (Fig. 3A). An alignment of these three docking domain
structures with each other shows strong agreement (RMSD of less
than 0.7 for all Cα atoms), indicating that this domain moves as a
rigid body (Fig. S3C). To further explore the flexibility of the
docking domain, a 20-ns molecular dynamics (MD) simulation of
the fully hydrated protein was run. Little movement of the Cy
domain was observed in comparison with the docking domain,
which sampled a larger range of positions especially during the first
5 ns of the simulation (Fig. 3B and Movie S1). None of these
conformations were observed to make substantial interactions with
the Cy domain; thus, the connection between domains appears
largely dependent on the covalent linker.
Structures Suggest T-Domain Binding Sites. The EpoB Cy domain
has the challenging task of interacting with carrier T domains from
two separate proteins, each of which supply a different component
to make 2-methylthiazoline (Fig. 1). Because EpoBdd facilitates
interactions with the PKS T-domain of EpoA, the location of
the docking domain in our structures identifies the approximate
binding site for EpoA-T (referred to as site 1 in Fig. 4A). Of the
three observed conformations of EpoBdd (Fig. 3A), R32b is the
closest to site 1, whereas the P21 domain position is ∼10 Å far-
ther removed and R32a is yet another ∼10 Å farther. Superim-
position of EpoBcy with the recently reported structure of a
holoenzyme T–E bidomain from gramicidin synthetase (23)
provides further support for this upstream T domain binding site
(Fig. S5A). The T domain in the gramicidine synthetase is ad-
jacent to the R32b-position of EpoBdd when the EpoB Cy do-
main and gramicidine synthase E domains are superimposed.
Insight into the binding location for the NRPS EpoB-T domain
comes from two structures of NRPS modules: the terminal surfactin
A module (18) and the terminal holo-AB3403 module (19), in
which the internal T domain of each module is positioned to in-
teract with its C domain. Structural superimposition (Fig. S5 C and
D) identifies the EpoB-T binding site as site 2 in Fig. 4A, a position
that is at the interface of the N- and C-terminal halves of the Cy
domain and is proximal to α1 and α10 (Fig. S2). Putative upstream
and downstream T domain binding sites 1 and 2 (Fig. 4A) are
nonoverlapping, consistent with the proposal that both T domains
bind EpoBcy at the same time (15). Intriguingly, the P21-EpoBcy
structure shows an extended L-shaped channel that connects pu-
tative T domain binding site 1 to the active site and the active site to
putative T domain binding site 2 (Fig. 4A). The distance between
each putative T domain binding site and the active site is ∼20 Å, the
length of an extended Ppant arm. This physical relationship sug-
gests an acetyl moiety tethered via a Ppant arm from the EpoA-T
domain would sit juxtaposed to a L-cysteinyl moiety tethered via a
Ppant arm from the EpoB T domain (Fig. 4B). Interestingly, a
superimposition of EpoBcy with the terminal holo-AB3403 module
(19) positions the Ppant arm bound in the holo-AB3403 structure
into the EpoBcy site 2 channel (gray in Fig. 4B), demonstrating
conservation of the channel position at least between these two
structures. In contrast to this conservation, superimposition of
EpoBcy with gramicidine synthase E domain does not result in the
placement of the Ppant arm bound to the E domain into the
EpoBcy site 1 channel (green in Fig. 4B and Fig. S5B). Inspection
of the structural superimposition (Fig. S5B) shows that four
β-strands in the E domain structure are shifted with respect to the
equivalent strands in EpoBcy creating an alternative channel that
is positioned next to, and not overlapping with, the channel in
EpoBcy. The latter provides an example of how small structural
differences may influence substrate positioning.
The three EpoBcy structures show channels with different de-
grees of openness due to variations in surface loop positions and in
side chain positions (Fig. 4 B–D and Fig. S6). To investigate the
conformational dynamics of residues near the active site that may
allow for channel widening and clamping, we carried out MD
simulations on the R32 structure that had the contracted cavity
(shown in Fig. 4D). As mentioned above, in a 20-ns MD simula-
tion, the Cy domain does not move substantially; however, certain
protein residues located on both sides of the active site appear to
undergo small movements of their backbone and slightly larger
movements of side chains, with the result being that the cavity
opens to resemble the contiguous channel observed in the P21
structure (Fig. 4E). These data suggest that small movements of
residues can alternately contract and widen channels between the
two T domain binding sites and the active site without the need for
large movements of the protein backbone.
Fig. 3. The PKS-NRPS docking domain is flexibly tethered to EpoBcy.
(A) Structural alignment of the three monomeric forms of EpoBcy observed
from the P21 and R32 crystal structures. The Cy domain is colored as in Fig. 2,
and the three observed orientations of the docking domain are colored cyan,
pale cyan, and blue. (B) A 20-ns MD simulation of EpoBcy with increased
protein movement indicated by the color of the protein trace, from blue (least
motion) to red (greatest motion). The EpoBcy cα trace is displayed in ribbons.
Also see Movie S1.
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Structure and Mutagenesis Reveal Unexpected Location for Cy Active
Site. The N- and C-terminal halves of the EpoB Cy domain form a
stable interface, which in turn forms the putative substrate-binding
channels that were described above. In addition to several hydro-
phobic residues that may mediate favorable interactions with the
hydrophobic Ppant arm and acetyl moiety of substrate, the structure
reveals a set of previously uncharacterized polar residues that may
be involved in catalysis, including S80, Y81, D354, Q445, and D449
(Fig. 5 A and B and Fig. S7). We mutated these residues and also
N335, which was studied previously in the homologous BacA system
(Table S3) (13). These six residues were mutated individually and
assayed for activity using LC/MS-MS detection, monitoring for-
mation of 2-methylthiazole-4-carboxlic acid (2MTCA) (Fig. S1).
Three active site variants have severely compromised rates of
product formation: D449A, N335A, and Q445A have 2,000-, 555-,
and 140-fold decreased activities compared with WT EpoBcy (Fig.
5C). The S80A, Y81F, and D354A variants of EpoBcy display only
moderate effects with three-, six-, and sixfold decreased activities,
respectively. Putting these results in context with the structure has
allowed us to localize the active site to the C-terminal half of the Cy
structure, where the channel is lined with residues N335, Q445, and
D449 (Fig. 5 A and B).
Surprisingly, these active site residues occupy a site that is distal
to the previously identified DxxxxDxxS motif (15, 16), the latter of
which is on the N-terminal half of Cy (Fig. 5 A and B). The
DxxxxDxxS motif aligns well with the catalytic HHxxxDG motif of
NRPS C domains as predicted (13, 16, 17) (Fig. 2B), but instead of
playing a catalytic role, our structures suggest that the DxxxxDxxS
motif (D201-LINVDLG-S209 in EpoBcy) may be important for
maintaining the integrity of the substrate channels. Importantly,
neither Asp is free to interact with substrate. Rather, D201 is in-
volved in a salt bridge with R85, which provides structure to one
side of the channel, and D206 forms a salt bridge with R341 and a
hydrogen bond to S209, supporting another side of the channel
(Fig. 5 A and B).
Discussion
Hybrid PKS-NRPSs are remarkable macromolecular assembly lines
with carrier proteins delivering substrates from one enzyme module
to the next and docking domains providing the intermodular
communication that allows for the proper directionality (14, 25, 26).
Our structures provide a visualization of the interactions between
an N-terminal docking domain and a downstream enzyme within a
NRPS module, and we find a bead-on-a-string type arrangement.
Fig. 4. Proposed binding sites for substrate T domains. (A) P21-EpoBcy (colored as in Fig. 2) is displayed in ribbons with the putative active site channels
displayed in green and gray (calculated by HOLLOW) (32). The binding of EpoA-T at site 1 is predicted by proximity to the docking domain and is shown as a
red sphere; EpoB-T (orange) is modeled at site 2 from the structural alignment of EpoBcy with AB3403 (19) that is shown in Fig. S5. Cavities are the ap-
proximate length of the Ppant prosthetic group (dashed orange and red lines). (B) Close-up view of active site channels from P21-EpoBcy structure. Locations
of the EpoA-T and EpoB-T domains represented as in A. A Ppant arm is modeled in the site 2 channel (gray) based on the superimposition of EpoBcy with holo-
AB3403, and a squiggly line represents the Ppant in the site 2 channel (green). The location of the catalytically important residues D449, N335, and Q445 are
indicated. (C) Channel calculation for R32-EpoBcy molecule A shows less connectivity between the site 1 channel (green) and the site 2 channel (gray) than in
the most open channel, which is shown in B. Residues shown as sticks have different positions in the open channel; carbons are colored purple if from the
N-terminal domain and yellow if from the C-terminal domain. (D) Channel calculation for R32-EpoBcy molecule B shows the most restricted internal cavities.
(E) The 20-ns MD simulation of most closed EpoBcy R32 structure (molecule B, shown in D), leads to an opening of the channel such that this channel now
resembles the channel of the P21 structure in B (residues from MD simulations are colored gray).
Dowling et al. PNAS | November 1, 2016 | vol. 113 | no. 44 | 12435
BI
O
CH
EM
IS
TR
Y
Covalent attachment by a 20-residue linker is all that is involved;
EpoBdd makes no other contacts to the Cy domain. Thus, any
docking domain could be substituted for EpoBdd with no reen-
gineering of the Cy domain protein surface required. This result
expands on the previous finding that switching EpoA modules can
result in transfer of the different substrate unit to EpoB (27). Al-
though EpoBdd is highly flexible, allowing it to search for its partner
proteins, its attachment point to Cy appears key to its function.
When EpoBdd localizes the EpoA-T to Cy through interaction with
EpoAdd, the T domain will end up positioned near to one of two
channel openings on Cy (site 1), allowing a substrate linked by a
Ppant arm to reach down into the core of the Cy domain.
A second channel from a second T domain binding site (site 2)
has been identified that is at a right angle from the site 1 channel.
The existence of two channels allows for simultaneous binding of
the two substrate-loaded T domains. By physically isolating the
binding sites of the upstream and downstream carrier proteins,
NRPS systems have developed a directionality that is important for
defining the generation of a specific natural product. The length of
each channel (∼20 Å) matches the length of an extended Ppant
arm (∼20 Å), allowing us to predict that the acetyl moiety from
EpoA-T and L-cysteinyl moiety from EpoB-T will end up juxta-
posed in the active site and also proximal to catalytic residues D449
and N335 (Fig. 4B and S7C). Notably, the EpoA channel appears a
bit longer than necessary for an acetyl moiety to be accommodated
(Fig. 4 A and B), perhaps explaining the observation that larger
substrates (propionyl-, isobutryl-, and benzoyl-EpoA-T) can be
turned over by Cy, albeit more slowly (10).
In our structures and MD simulations, we observe snapshots of
more open and more closed states of the channel leading to the
active site, and we expect that the binding of EpoA-T and EpoB-T
domains at their respective binding sites will shift the equilibrium
toward the more open state and that T domain departure will shift
toward the closed state, thus restricting active site access in the
absence of substrates. Although conformational changes of protein
backbone have been observed for C domain proteins that could
contribute to channel opening and closing (20), here we see little to
no movement of the backbone atoms of the three structures that
display various degrees of channel openness. Also, MD simulations
show that side chain motion is sufficient to open and close the
internal protein cavities. Thus, for this Cy domain, there appears to
be no need to invoke domain hinge motions in catalysis.
These studies have also allowed us to investigate how a Cy domain
compares to a C domain. We find that the EpoB Cy domain adopts
a similar protein fold as the NRPS C domain, validating previous
predictions (15), but we also find that the catalytically important
residues for Cy do not map to the location of the highly conserved
sequence motifs (HHxxxDG for C domains and DxxxxDxxS for Cy
domains). Importantly, residues of the DxxxxDxxS sequence motif
are not free to interact with substrate, instead forming salt bridges
and hydrogen bonding networks that stabilize the elaborate channels
that run through the core of the protein fold. Although substrate
binding might cause residues of the DxxxxDxxS motif to break their
interactions and be available for catalysis, we instead propose that
D449 is key to catalysis, potentially serving as a catalytic base. This
proposal is consistent with the 2,000-fold effect on 2MTCA pro-
duction when D449 is mutated to alanine.
Inspection of the proposed mechanisms in Fig. 1B shows a
number of base-catalyzed steps that might be involved in this three
step reaction: deprotonation of the amino group of cysteine for the
peptide bond formation step with the acetyl moiety; deprotonation
of the cysteine side chain for the cyclization reaction; and depro-
tonation of the ring NH for the dehydration reaction. It is possible
that one residue may catalyze all three deprotonations, because the
protonation state of the base could be reset after each step. No-
tably, the number of deprotonations equals the number of pro-
tonations, with the Ppant sulfur accepting one proton and the acetyl
moiety oxygen accepting two protons as it is first reduced to a hy-
droxy group and then to water (Fig. 1B). Thus, from the perspective
of stoichiometry, D449 could assist in all three reactions, but a
structure with substrate bound would help to evaluate the geometric
prospects of a single residue catalyzing all three different steps.
We also confirmed that N335 is catalytically important, having
a 555-fold effect on 2MTCA production. Given that the cor-
responding asparagine residue in a chimeric engineered BacA Cy
generated only an uncyclized dipeptide product when this aspar-
agine was mutated to alanine (13), we expect that N335 is also
involved in cyclization. Because N335 does not have a titratable
side chain, we do not believe that it is a catalytic base. Instead, it
may serve to position the substrates appropriately for cyclization or
stabilize intermediates through hydrogen bonding. In short, the
structures of EpoBcy explain much of the previous biochemical
work and also reveal D449 as a key residue, although there is still
much to be learned about this fascinating cyclization chemistry.
Since the discovery of NRPS natural products, researchers have
been interested in manipulating these modular assembly lines for
the bioproduction of novel chemical compounds (6, 26, 28, 29). For
this to be achievable and efficient, we must increase our under-
standing of how these systems function at the molecular level (28).
This work presents important structural information regarding two
NRPS domains: the Cy domain that produces five-membered
heterocycles for assembly into larger NRPS products and the
docking domain that provides specificity between two different
PKS-NRPS proteins to interact in trans.
Methods
The EpoBcy protein constructwas expressed and purified as previously described
(17), with minor modifications detailed in SI Methods. EpoBcy site-specific
mutagenesis was performed using standard protocols, and activity assays (17)
were adapted for product detection by LC/MS-MS (SI Methods). Purified WT
EpoBcy was crystallized using the vapor diffusion method, and X-ray diffraction
Fig. 5. Identification of EpoBcy active site residues. (A) Polar residues that
were mutated in this work are shown in sticks and colored with green
carbons, with asterisks denoting those mutations that most dramatically
affected enzyme activity. The previously identified D201xxxxD206xxS209
sequence is colored with orange carbons, and previously mutated residues
have gray carbons (see Table S3 for summary of mutational studies). R85 is
colored with purple carbons and has not been mutated. Channels colored as
in Fig. 4A and ribbons colored as in Fig. 2A. Stereoview is shown in Fig. S7.
(B) Same as A, but rotated ∼90° clockwise about the vertical axis to match
orientation shown in Fig. 4A. (C) Calculated rates of 2-methylthiazole-4-
carboxylic acid formation by LC/MS-MS for EpoBcy variants in this work. Data
are the average ± SD for three replicates.
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experiments, model building, and refinement are detailed in SI Methods. A 20-ns
MD simulation was performed in GROMACS (30), and parameters are described
in SI Methods.
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